Tower Research Capital LLC (Trc) Synaptogenix, Inc. Transaction History
Tower Research Capital LLC (Trc)
- $4.07 Billion
- Q1 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Synaptogenix, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 102 shares of SNPX stock, worth $410. This represents 0.0% of its overall portfolio holdings.
Number of Shares
102
Previous 386
73.58%
Holding current value
$410
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding SNPX
# of Institutions
25Shares Held
955KCall Options Held
0Put Options Held
0-
Jim Simons Renaissance Technologies LLC | New York, Ny401KShares$1.61 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA154KShares$620,9730.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il83.5KShares$335,8460.0% of portfolio
-
Two Sigma Securities, LLC New York, NY83.4KShares$335,3040.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA68.5KShares$275,4580.0% of portfolio
About Synaptogenix, Inc.
- Ticker SNPX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 6,840,630
- Market Cap $27.5M
- Description
- Synaptogenix, Inc. operates as a biopharmaceutical company with product candidates in pre-clinical and clinical development. It focuses on developing a product platform based upon a drug candidate called Bryostatin-1 for the treatment of Alzheimer's disease. The company is also evaluating therapeutic applications of bryostatin for other neurodeg...